IB Lab’s mission is to enhance patients diagnostic experience and go beyond the current standard of care. Currently, 70 million people suffer from OA in Europe alone. By 2040, this number is predicted to exceed 100 million. Diagnoses are often too late, subjective and might lag details due to time pressure. This demands a solution – now. IB Lab uses state-of-the-art computer-vision and artificial intelligence technology to efficiently solve these problems.